Status:
COMPLETED
Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
Lead Sponsor:
Tottori University Hospital
Conditions:
Chronic Stable Heart Failure
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.
Detailed Description
Diuretics is useful in CHF patients. On the other hand, they deteriorate glucose metabolism. Therefore, the purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin...
Eligibility Criteria
Inclusion
- chronic stable heart failure
Exclusion
- renal dysfunction or under treatment with antidiabetic agents
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00664222
Start Date
January 1 2004
End Date
December 1 2005
Last Update
April 22 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.